| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.89B | +12.2% |
| Cost of Revenue | $438.1M | +34.4% |
| Gross Profit | $1.45B | +6.9% |
| R&D Expense | $73.8M | +4.1% |
| SG&A Expense | $474.2M | +16.9% |
| Operating Income | -$126.3M | -65.1% |
| Interest Expense | $20.1M | -14.4% |
| Pre-tax Income | -$145.2M | -41.7% |
| Income Tax | -$17.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $321.2M | -25.0% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $93.9M | +11.2% |
| Current Assets | $484.2M | -17.0% |
| Total Assets | $1.91B | -5.1% |
| Current Liabilities | $281.8M | +1.9% |
| Long-term Debt | $495.3M | +0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.1M | +336.0% |
| Capital Expenditures | $116.4M | +65.7% |
| Investing Cash Flow | -$116.1M | -157.6% |
| Financing Cash Flow | -$17.2M | +95.0% |
| Free Cash Flow | -$89.3M | -39.5% |
| +46.1% |
| Net Income | -$128.4M | -80.0% |
| EPS (Basic) | -$0.26 | -85.7% |
| EPS (Diluted) | -$0.26 | -85.7% |
| Stockholders' Equity |
| $1.05B |
| -7.6% |